PlentiPlex™ MSI assays are intended for evaluation of impaired mismatch repair (MMR) and the resulting microsatellite instability affecting prognosis and selection of treatment in cancer patients. PlentiPlex™ MSI assays offer two different multiplexed MSI assays for the length analysis of five microsatellite loci. This makes PlentiPlex™ MSI assays valuable stratification tools for assisting cancer treatment planning.
Advantages of PlentiPlex™ MSI:
Simple MSI stratification of solid tumors for treatment guidance
Simplified four-step workflow
Well-known validated loci
Minimal hands-on time